FDA panel votes against approving COVID booster shots to general public

FDA panel votes against approving COVID booster shots to
general public 1

WHITE OAK, MD – JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Images)

OAN Newsroom
UPDATED 7:09 PM PT – Friday, September 17, 2021

A Food and Drug Administration (FDA) advisory committee halted the Biden administration’s push to administer booster shots for Pfizer’s COVID-19 vaccine. On Friday, an advisory panel to the FDA voted not to fully approve the booster shots for the Pfizer vaccine.

Only two committee members voted in favor of adding a jab, but the move was squashed by the remaining 16. The Biden administration initially wanted to get booster shots in the arms of Americans as soon as next week. However, the committee was hesitant to greenlight the added jabs, claiming Pfizer didn’t provide sufficient data showing booster shots were safe or necessary.

Although, the panel did vote unanimously to give the go ahead on the shots for Americans ages 65 and older. Additionally, those at higher risk of contracting COVID-19, including the immunocompromised, were also advised to get the booster.

The vote comes as two senior FDA officials stepped down at the beginning of the month over pressure by the White House to recommend a third injection of the vaccine.

In the meantime, the FDA has the final say as to whether to approve the booster and critics have said the advisory board’s decision shows Biden’s push to add a jab to Americans is out of tune with top health experts.

MORE NEWS: Texas Gov. Abbott Signs $1.8B Border Bill, Says Was Forced To Due To Biden’s Inaction

Read the Full Article

McAuliffe, Youngkin Clash On Vaccine Mandates, Abortion In First Debate For Virginia Gubernatorial Race
Exclusive — Sen. Ron Johnson Demands to Know Why Biden Banned Drone Coverage of Migrant Surge

You might also like